Park Ha Biological Technology Co., Ltd.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Park Ha Biological Technology Co., Ltd. now
Current reporting with the operating signal separated from the noise.
Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
The story matters when it changes Park Ha Biological Technology Co., Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.ROSEN, LEADING INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
The story matters when it changes Park Ha Biological Technology Co., Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit
The story matters when it changes Park Ha Biological Technology Co., Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Rosen Law Firm Urges Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Investors are testing whether Park Ha Biological Technology Co., Ltd.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.INVESTOR NOTICE: Morris Kandinov LLP Announces Securities Class Action Involving PARK HA BIOLOGICAL TECHNOLOGY CO., LTD. (BYAH, formerly PHH) And the Deadline for Lead Plaintiff Applications
The development tests whether Park Ha Biological Technology Co., Ltd. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.BYAH Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Park Ha Biological Technology Co., Ltd.
Investors are testing whether Park Ha Biological Technology Co., Ltd.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Park Ha Biological Technology Co., Ltd. Revenue Breakdown – NASDAQ:BYAH
Investors are testing whether Park Ha Biological Technology Co., Ltd.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest BYAH filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Park Ha Biological Technology Co., Ltd., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →